The paradoxical effect of bevacizumab in the therapy of malignant gliomas

Keyphrases

• Bevacizumab 100%
• Malignant Glioma 100%
• Paradoxical Effect 100%
• Infiltration 50%
• Newly Diagnosed 50%
• Blood-brain Barrier 50%
• Histologic 50%
• Beneficial Effects 50%
• Therapeutic Efficacy 50%
• Tumor Progression 50%
• Vascular Endothelial Growth Factor 50%
• Oxygen Delivery 50%
• Genentech 50%
• Cytoreductive Surgery 50%
• San Francisco 50%
• Radiochemotherapy 50%
• Antiangiogenic Agents 50%
• Permeability Characteristics 50%
• Tumor Vasculature 50%
• Pseudoprogression 50%
• Low Permeability 50%
• Radiotherapy Efficacy 50%
• CNS Malignancies 50%
• Avastin 50%
• Tumor Interstitial Fluid Pressure 50%

Medicine and Dentistry

• Glioblastoma 100%
• Bevacizumab 100%
• Neoplasm 33%
• Cancer 33%
• Combination Therapy 33%
• Chemoradiotherapy 33%
• Vasculotropin 33%
• Tumor Progression 33%
• Angiogenesis Inhibitor 33%
• Blood Brain Barrier 33%
• Tumor Vascularization 33%
• Radiation Therapy 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Glioblastoma 100%
• Bevacizumab 100%
• Neoplasm 33%
• Combination Therapy 33%
• Tumor Growth 33%
• Vasculotropin 33%
• Angiogenesis Inhibitor 33%
• Tumor Vascularization 33%
• Blood-Brain Barrier 33%